Pre-market
Loading markets…

Advertisement

Stocks/NASDAQ/SLN

Silence Therapeutics PLC (SLN : NASDAQ)

Common Stock

$19.58

USD

+10.90 (125.58%)

Last updated: 2026-10-19

Follow SLN

SLN

Silence Therapeutics PLC

Source:WealthAwesomeWealthAwesome
↑ $5.89 (43.02%)
30 day period
$8.68$14.13$19.58Sep 8Sep 29Oct 19

Performance

1 Day

+125.58%

1 Week

+102.90%

1 Month

+60.49%

YTD

+189.64%

Key Statistics

Market Cap

$1.22B

52W High

$19.61

52W Low

$4.19

P/E Ratio

-

50 Day MA

$12.46

200 Day MA

$8.43

Beta

1.45

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/19/2026$19.59$19.61$19.56$19.58$19.5871,902,568
10/16/2026$9.10$9.22$8.66$8.68$8.681,131,100
10/15/2026$8.81$9.46$8.81$9.35$9.351,449,372
10/14/2026$8.91$9.27$8.85$8.98$8.981,232,785
10/13/2026$9.53$9.56$8.71$8.87$8.871,450,178
10/12/2026$9.70$10.36$9.58$9.65$9.65550,992
10/9/2026$9.45$10.39$9.45$9.86$9.86844,300
10/8/2026$9.71$9.72$9.05$9.52$9.521,109,564
10/7/2026$9.77$10.14$9.60$9.82$9.821,319,569
10/6/2026$10.12$10.19$9.63$9.83$9.831,581,371

Analyst Price Targets

Based on 7 analysts covering SLN · as of Oct 20, 2026

📈

Wall Street analysts forecast SLN stock price to rise 62.4% over the next 12 months.

Consensus

Buy

4.29 / 5.00

Avg. Target

US$31.80

+62.4% Upside

Previously US$33.00 on Oct 5, 2026

Current Price

US$19.58

Last close

Analyst Breakdown (7 analysts)

Strong Buy 5
Buy 1
Strong Sell 1
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on SLN's historical volatility

HistoricalForecast68%95%
US$1.20US$91.97US$182.73US$273.50US$364.26US$455.03TodayJun 17Aug 19Oct 19Dec 1Jan 14Feb 26

30-Day Vol

245.8%

Annualized

90-Day Vol

164.9%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

US$23.41

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$20.78US$8.90 – US$48.52
60 trading daysUS$22.06US$6.65 – US$73.18
90 trading daysUS$23.41US$5.39 – US$101.69

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Silence Therapeutics PLC

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.

Financials

Revenue (TTM)
$615,000
EBITDA
$-63.94M
Profit Margin
0.00%
ROE (TTM)
-90.41%
EPS (Diluted)
-1.29
Book Value
0.81

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About SLN.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
FRGTFreight Technologies Inc$1.47+97900.00%
GPGreenPower Motor Company Inc$1.46+11217.83%
MBRXMoleculin Biotech Inc$5.26+1775.89%
REVBRevelation Biosciences Inc$3.29+577.76%
SXTCChina SXT Pharmaceuticals Inc$0.11+71.08%
AFJKRAimei Health Technology Co., Ltd Right$0.14+64.47%
XHGXChange TEC.INC$3.20+60.00%
SOBRSobr Safe Inc$0.07+39.81%

Advertisement